Halozyme discloses minimal SVB exposure; deposits insured, custodial accounts at separate banks

HALOZYME THERAPEUTICS, INC.

Cash deposit at SVB under $250,000 FDIC limit as of March 10, 2023.
Majority of cash and investments held in custodial accounts at independent institutions; SVB is agent only.
SVB is a lender on $575M credit facility with $39M commitment; no current draws and no plans to draw.
Treasury/Fed/FDIC joint statement ensures all depositors are fully protected; money available March 13.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.